Part of iatrogenic event in the emergency consultation of elderly people: Epidemiological observational prospective study

##plugins.themes.academic_pro.article.main##

Sarra Jouini
Olfa Djebbi
Sami Souissi
Béchir Bouhajja

Abstract

Background: Emergency units are one of the main access roads to the hospital for the elderly people. Research on adverse drug related events therefore find a field of study previligie.
aim: To analyze the part of iatrogenic event in the emergency consultation of elderly people, and identify class of drug responsible.
methods: We conducted a prospective chart review on treatments and potentials adverse drug-related events on all elderly patient consecutively presented in emergency unit of Ben Arous hospital in August 2008. We conducted a comparative study between: adverse drug related group and no adverse drug related group.
results: Two hundred one elderly patients were prospectively included. Eighty –four per cent are medicated. The number of medications consumed ranged between 0 to 11 and averaged 2, 85 drugs. Adverse drug related events accounted in 28 cases (16, 5%).There were no difference in demographic characteristic and drugs consumed between the two groups. However the treatments were recently modified more frequently in adverse drug related group.Drugs more frequently associated with adverse events were no steroidal anti-inflammatory in 37% cases and Anti vitamin K or warfarine in 20% cases. Patients of drug related events group need more prescription modification at discharge.
Conclusions: We note polymedication in frail elderly patients presented to emergency unit. Adverse drug related events were frequent and favorised by recent modified prescription.

Keywords:

Drugs, elderly, adverse events, emergency-unit.

##plugins.themes.academic_pro.article.details##

References

  1. Queneau P, Adnet F, B annewar th B, Carpentier F, Bou get J, Trinh - Duck A. Iatrogènie comme moti f d e reco urs au x urg ences. SFMU 2007 ; 47:427-40.
  2. Lazarou J. In ci dence o f adve rs e drug reactions i n ho spit al iz ed patients. J AMA 1 998; 279: 1200-5.
  3. Tubéry M. R epérag e e t p révention d 'un e pathol ogie iatr ogèn e. S FMU 2007 ;49 :443-449.
  4. Quene au P, Cha bot JM, Rajoana H, et al. Iatrogénie obser vée en milieu hospi talier. A p rop os d e 109 cas collig és à partir d'u ne enquête transversale de l' APNET. Bull Acad Med 1992 ; 176 :511-29.
  5. Thi essard F, Rou x E, M iremont-Salame G, e t al. Trends in sp ont a ne ous adv erse d ru g r eact ion repo r ts t o the French pharmaco -vigil ance system. Drug Saf 2005; 28: 731-40.
  6. F radet G, Legac X, Charloi s T, Ponge T, Cottin S. P at hologie i atr ogène m éd icamente use après 6 5 a ns res pons ab le d'un e hos pitalisa tion . Etude rétrospec tive sur u n an da ns un service de médec ine interne. Re v Med intern 1996 ;17:4 56-60.
  7. Quene au P, Ba nnwart h B, Carp entier F, e t al. Effe ts indési rabl es médicamenteu x observés dans les services d'accu ei l et des urge nces français. Etude prospec tive de l' APNET et p rop osit ions pou r de s mes ur es pré ve nti ve s. B ull Acad Natl Med 20 03; 187:647-70.
  8. Schmidt J . Iatrogénie ind uite pa r l es so ins d'urge nces. SFM U 2007 ; 48 :4 41- 46.
  9. AL Fa uch ai s, I Ploquin, K Ly, et a l. Iat rog énie chez le sujet âgé de plus de 75 an s dans un se rvice de post urgences . Et ude prospectiv e de cohorte avec s uivi à six mois . Rev Med In te rn 2006 ; 27:375-81.
  10. B oude jourou- Camus MC, Kariger E, Novella S, Bl anchard F. L es accid ents iatrogènes méd ic am enteu x chez l es personnes âgées. R ev G eriatr 1 998; 23:477 -85 .
  11. C armen C, Suciu M, Voicu M, Drag an L, B umbacila B. A short re view of drugs which present an incr eased iatrogenic risk in elderly p at ie nts. T hera Pha rmacol Cl in Toxicol 2010; 14:132-39.
  12. Manesse CK, Derk x F, De Ridder M , et al . Adverse d rug reactions in elderly pa tients as con tribut ing factors f or hosp ital ad mission: cross se ct ional study. BMJ 1997; 315: 1057-58.
  13. Am inze dah F, Dalziel WB . Older adults i n the emerge nc y department: A systematic revi ew of patterns of use, adverse ou tc omes and effective ness of interventio n. Ann Emerg Me d 20 02; 3 9:238-47.
  14. Hohl CM, Dankoff J, Colacone A, et al. Polyp harmacy, adverse drug re la ted events, and potential a dverse drug int eractions i n elderly pa tients pre sen ting to an e me rgency department. An n Emerg Med 2001; 38:6 66- 71.
  15. Goutier S, Bordet R, C aron J. Princ ipales urg ences ia trogènes médicament eus es . EMC Médecine d'urg ence 2007;H10:25 -30 .
  16. Pa uyan ne P, Haramb ur u F, Imbs JL, Be gau d B . Admissions t o h ospital caus ed by adv ers e d r ug rea ctio ns: cro ss s ect ion al incide nce s tudy. BMJ 2 000;32 0:1036-40.
  17. Bordet R, Gau tier S, Le louet H, D upuis B, Caro n J. Analysis of the direc t cos t o f a dve rs e drug rea ctions in hos pitalized pa tients . Eur J C lin Pharmaco l 20 01;56:935-41.
  18. Labetoulle M . Iatrogénie : quelle amp le ur, pourquoi et comm ent la réduire? J Fr Ophtalmol 2009;32:79 -8 2.
  19. Queneau P, Grandmoutet P. Prév ention de la i at rog énie évit able: Le devoir de vigilance. Press Med 1998;27:12 80- 82.
  20. Sc hmidt J, Mous ta pha F, Lac roix M. Iatro génie interfé rences médicament euses . S FMU 2010;68 :779-793.
  21. Fa ulx M, Fra ncis GS. Adverse dr ug reaction in pati ents wit h card iovascular disease. Curr Probl C ardio l 200 8;33: 703-68.
  22. Lazarou J, P romeranz BH, Corey PN. Incidence of adv erse dru g reactions in hosp italized patients : a meta-analy sis of pro spe ct ive s tudies. JAMA 1998;279:1 200-5.
  23. Hansson L, Ekbom T. Antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity. Circulation 2001;99:354-362.
  24. Pres crire che z le sujet âg é d e plus de 75 ans o u de plu s de 65 ans et polypat hologique . HAS 2006.
  25. Ca rpent ie r F, Fi carelli A, Huar t H, et al.10 ème conférence de consens us. Prise en charg e de la personne âgée de plus de 75 ans aux urgence s. SFMU 2003;14:1-19.